Clinical Projects

Ongoing:

ASPIRED: ASPirin Intervention for the REDuction of colorectal cancer risk (NCT02394769) – Massachusetts General Hospital. Find the protocol here!

Feasibility of the LUM Imaging System for the Detection of Gastrointestinal Cancers (NCT02584244) РMassachusetts General Hospital/Lumicell Inc.

Past:

“Are ACF surrogate markers of colorectal cancer risk?” (PI: Daniel W. Rosenberg) – University of Connecticut Health Center)

 

 

Massachusetts General Hospital / Harvard Medical School